A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Maintaining the right level of sugar in the blood is the responsibility not only of insulin, which removes glucose, but also of a hormone called glucagon, which adds glucose.